Respiratory Device Company Strados Labs Raised $4.5M, With 2022 Hiring Plans

Strados Labs, maker of a non-invasive respiratory smart device and system, has raised $4.5 million with plans to grow its team and scale its platform for more trials.

CEO and cofounder Nick Delmonico told that cultivate(MD), a medical device venture capital fund, was this round’s lead investor — a “perfect fit,” the CEO said. Local investor Broad Street Angels, as well as SOSV, contributed follow-on funding, and Wavemaker360 Health and Blu Venture Investors also participated. Delmonico called the investors a group that “knows the stage really well.”

The team is considering this round a pre-Series A, and it brings the company’s total funding to just over $7 million, the CEO said. It’ll be focused on moving product commercialization forward in the pharma and clinical trials market. The devices allow clinicians to remotely monitor a patient’s respiratory performance with a wearable stethoscope-like biosensor device that “computerizes” lung sounds.

Read the full article here.